Molecular diagnostic company.
Active 2018–2026. The register lists this client once for every firm that files on its behalf; all 9 of its records are shown together here.
These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | TODD STRATEGY GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$40,000 | |
| 2026 | BLOUNT STRATEGIC INITIATIVES |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$10,000 | |
| 2026 | TIBER CREEK GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$40,000 | |
| 2026 | MYRIAD GENETICS, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report (No Activity) |
— | |
| 2026 | TODD STRATEGY GROUP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$40,000 | |
| 2026 | MYRIAD GENETICS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report (No Activity) |
— | |
| 2026 | TIBER CREEK GROUP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$40,000 | |
| 2026 | GUIDE CONSULTING SERVICES, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination |
$30,000 | |
| 2026 | BLOUNT STRATEGIC INITIATIVES |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$10,000 | |
| 2026 | TIBER CREEK GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$40,000 |
| Firm | Filings | Amount |
|---|---|---|
| MYRIAD GENETICS, INC. IN-HOUSE | 34 | $7,256,000 |
| TODD STRATEGY GROUP | 31 | $1,170,000 |
| GUIDE CONSULTING SERVICES, INC. | 34 | $930,000 |
| BLUEBIRD STRATEGIES | 21 | $590,000 |
| THE NICKLES GROUP, LLC | 9 | $380,000 |
| TIBER CREEK GROUP | 10 | $300,000 |
| BLOUNT STRATEGIC INITIATIVES | 19 | $180,000 |
| FAEGRE BAKER DANIELS CONSULTING | 8 | $50,000 |
| FOLEY HOAG LLP | 8 | $5,000 |
| Issue | Activities |
|---|---|
| Medicare/Medicaid | 112 |
| Health Issues | 75 |
| Medical/Disease Research/Clinical Labs | 71 |
| Veterans | 40 |
| Budget/Appropriations | 26 |
| Copyright/Patent/Trademark | 3 |
| Insurance | 1 |